Boston Scientific Corporation
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
FY2007
Total Cash from Operations: $1.11B
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $233.2M | 21.0% |
| Business Acquisitions | $260.8M | 23.5% |
| Stock Repurchases | $500.0M | 45.0% |
| Other Financing | $106.0M | 9.5% |
| Net Cash Flow | $10.0M | 0.9% |